Cell & Gene Therapy Trials: Personalized Trial Execution (Chapter 1 of 5)

Adam Callahan explains how a personalized approach can shape cell and gene therapy trial execution. Caidya tailors its engagement and governance models to each sponsor’s structure, therapeutic focus, and needs, whether supporting a small company conducting its first-in-human study or a larger organization with multiple stakeholders. The discussion also explores the role of vendor coordination in complex trials. Adam describes how teams select and manage providers for pharmacokinetic and pharmacodynamic testing, donor sample processing, translation, IVRS, CDMO, and CMC services. Careful coordination helps ensure that samples move between sites, laboratories, and sponsors within the required timeframes.